X0508 4 2025-11-18 0 0001676238 Braze, Inc. BRZE 0001889752 Wiseman Susan C/O BRAZE, INC., 63 MADISON BUILDING 28 E. 28TH ST., FLOOR 12 MAILROOM NEW YORK NY 10016 0 1 0 0 General Counsel 1 Class A Common Stock 2025-11-18 4 S 0 5474 26.64 D 224250 D Class A Common Stock 2025-11-20 4 S 0 3248 27.35 D 221002 D Class A Common Stock 2025-11-20 4 S 0 1208 28.17 D 219794 D This transaction was effected in accordance with a non-discretionary sell-to-cover program implemented by the Issuer, effective November 16, 2021 and last modified April 30, 2023, to satisfy tax withholding obligations arising in connection with the vesting of the Reporting Person's restricted stock units. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.64 to $26.80 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Of the reported shares, 78,887 shares are represented by restricted stock units. Shares were sold pursuant to a Rule 10b5-1 trading plan adopted on April 14, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.95 to $27.91 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.96 to $28.46 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Nathan Jeffries, Attorney-in-Fact 2025-11-20